|
|
Merck Announces FDA Acceptance of Supplemental New Drug Application for ISENTRESS® (raltegravir) in Adult Patients ... (Business Wire via Yahoo! Finance) |
 |
 |
|
WHITEHOUSE STATION, N.J.----Merck & Co., Inc. today announced that the U.S. Food and Drug Administration has accepted the supplemental New Drug Application filing for ISENTRESS® Tablets for standard review. read more |
|
|
Why Does US Health Care Cost So Much? (Part IV: A Primer on Medicare) - New York Times |
|
|
|
... Americans aged 65 or older, as well as younger people with permanent disabilities, among them patients afflicted with End Stage Renal Disease (ESRD). ... read more |
|
Research and Markets: Egypt Nephrology and Urology Devices ... - MarketWatch |
|
|
|
... In Egypt Renal Dialysis Equipment In Egypt HARTMANN GROUP Company Profile Kimberly-Clark Corporation Company Profile Fresenius Medical Care AG & Co. ... read more |
|
|
'Life Given Back' to New Mom by ABC News Colleague - ABC News |
|
|
|
By BOB BROWN This is a story about two friends, a kidney transplant, and the complications that arose along the way. We've come to take the transplants for ... read more |
|
La leptospirose : qu'est-ce que c'est ? - Web-Libre.org |
|
|
|
Au besoin, l'application d'un traitement dit symptômatique est requise avec le rétablissement de la dialyse et de l'hydroélectolytique. ... read more |
|
|
|
|
<< Start < Prev 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 Next > End >>
|
|
Page 2594 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
